Mayne Pharma (MYX AU): This One's On You Jim As Court Dismisses Cosette's Appeal
Mayne is 61% adrift of Cosette's Offer price. Yet, Mayne doesn't scream "buy" here. 5x+ forward EV/EBITDA is ok. The market is expecting EBITDA to...
56 Views
Mayne Disagrees With Cosette On MAC
Mayne Pharma (MYX AU) has released its FY25 results. They appear decent. (more detail in "Discussions" at the bottom). And nothing apparent to...
1.7k Views
Mayne Pharma (MYX AU): Court Rules Cosette Cannot Walk
Mayne has been provided with a letter received from the Treasurer indicating that his “preliminary view is that the Proposed Acquisition would be...
963 Views
Weekly Deals Digest (19 Oct) - Mayne, Soft99, Mandom, Kangji, Mandarin Oriental, Genting Malaysia
A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, NZ, Singapore, Japan, Indonesia,...
466 Views
Mayne Pharma (MYX AU): A Favourable Court Ruling
The ruling will provide more certainty regarding the interpretation of MACs. The scheme is subject to FIRB approval, which should be forthcoming....
771 Views